Author

Marije M. Vleugel

Observed names: M M Vleugel, M VLEUGEL, M.M. Vleugel, MM Vleugel, Marije M Vleugel, Vleugel, M.M.

Observed institutions: University Medical Center Groningen, The University of Texas MD Anderson Cancer Center, Sahlgrenska University Hospital, The Netherlands Cancer Institute, University Medical Center Utrecht, Waterlandziekenhuis, Michigan Medicine, Dana-Farber Cancer Institute, European Organisation for Research and Treatment of Cancer, Amsterdam UMC Location Vrije Universiteit Amsterdam, University of Edinburgh

OpenAlex ID: A5109230516

c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer

2006 · Marije M. Vleugel, Astrid E. Greijer, et al. · Human Pathology · 250

Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer

2005 · M M Vleugel, A E Greijer, et al. · Journal of Clinical Pathology · 227

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

2017 · Vivianne C G Tjan-Heijnen, Irene E G van Hellemond, et al. · The Lancet Oncology · 152

Lack of lymphangiogenesis during breast carcinogenesis

2004 · M M Vleugel, R Bos, et al. · Journal of Clinical Pathology · 113

p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer☆

2006 · M VLEUGEL, D SHVARTS, et al. · Human Pathology · 63

No Amplifications of Hypoxia‐Inducible Factor‐1α Gene in Invasive Breast Cancer: A Tissue Microarray Study

2004 · Marije M. Vleugel, Reinhard Bos, et al. · Analytical Cellular Pathology · 23

Expression of HIF-1alpha in human tumours.

2005 · P J van Diest, M M Vleugel, et al. · PubMed · 22

Mutation analysis of the HIF-1α oxygen-dependent degradation domain in invasive breast cancer

2005 · Marije M. Vleugel, Astrid E. Greijer, et al. · Cancer Genetics and Cytogenetics · 17

Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer

2026 · Elske C. Gootjes, Lotte Bakkerus, et al. · JAMA · 14

Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG)

2023 · Carolien P Schröder, Elise van Leeuwen-Stok, et al. · The Oncologist · 13

VEGF-D and HIF-1alpha in breast cancer.

2005 · P J van Diest, M M Vleugel, et al. · PubMed · 7

Abstract P5-23-01: Clinical and biological characterization of male breast cancer (BC) EORTC 10085/TBCRC 029/BOOG 2013-02/BIG 2-07: Baseline results from the prospective registry

2018 · SH Giordano, CP Schröder, et al. · Cancer Research · 3

VEGF-D and HIF-1α in breast cancer

2005 · P. J. van Diest, M M Vleugel, et al. · PubMed Central · 1

Differential prognostic value of hypoxia-induced and diffuse HIF-1a overexpression in invasive breast cancer.

2004 · M M Vleugel, A.E. Greijer, et al. · Breast Cancer Research and Treatment

Works count: 15

Citation count: 905

H-index: 10

I10-index: 10